CONMED Corporation (CNMD)

Interest coverage

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 118,079 171,907 181,271 200,326 198,014 162,607 142,918 120,604 69,322 63,270 -51,701 -41,956 -3,645 -2,309 110,951 108,589 95,985 99,694 52,652 45,653
Interest expense (ttm) US$ in thousands 32,573 34,219 35,988 37,296 37,944 38,711 39,115 39,776 39,714 38,231 34,162 28,905 27,031 26,640 30,132 35,485 39,030 42,828 44,809 44,050
Interest coverage 3.63 5.02 5.04 5.37 5.22 4.20 3.65 3.03 1.75 1.65 -1.51 -1.45 -0.13 -0.09 3.68 3.06 2.46 2.33 1.18 1.04

September 30, 2025 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $118,079K ÷ $32,573K
= 3.63


Peer comparison

Sep 30, 2025

Company name
Symbol
Interest coverage
CONMED Corporation
CNMD
3.63
Abbott Laboratories
ABT
19.22
Stryker Corporation
SYK
14.24